Johnson & Johnson (JNJ)
-NYSE 88.09 
0.64(0.73%) May 17, 4:02PM EDT|After Hours
:
88.38 0.29 (0.33%) May 17, 6:31PM EDT
| Prev Close: | 87.45 |
|---|
| Open: | 87.45 |
|---|
| Bid: | 87.95 x 300 |
|---|
| Ask: | 88.30 x 300 |
|---|
| 1y Target Est: | 86.50 |
|---|
| Beta: | 0.48 |
|---|
| Next Earnings Date: | 15-Jul-13 |
|---|
| Day's Range: | 87.41 - 88.20 |
|---|
| 52wk Range: | 61.71 - 88.20 |
|---|
| Volume: | 11,439,498 |
|---|
| Avg Vol (3m): | 9,721,630 |
|---|
| Market Cap: | 247.43B |
|---|
| P/E (ttm): | 23.92 |
|---|
| EPS (ttm): | 3.68 |
|---|
| Div & Yield: | 2.64 (3.00%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Johnson & Johnson and Merck Lead the Dow Healthcare Stock Rollercoaster Ride This Weekat Wall St. Cheat Sheet(Sun 11:25AM EDT)
- Further Analysis Of The 40 Stock Portfolioat Seeking Alpha(Sun 7:39AM EDT)
- This 10-Stock Dividend Strategy Is Trouncing the Dowat Motley Fool(Sat, May 18)
- Abbott Laboratories Stock Checkup for Mayat Motley Fool(Fri, May 17)
- [video] Companies That Shine After Spinoffsat CNBC(Fri, May 17)
- Final Glance: Medical Devices companiesAP(Fri, May 17)
- Final Glance: Pharmaceuticals companiesAP(Fri, May 17)
- J&J Will Stop Sales of Metal-on-Metal Hip Replacementsat Bloomberg(Fri, May 17)
- J&J, Up 25% YTD, Shrugs Off Risperdal SuitsYCharts(Fri, May 17)
- Jennifer Aniston: Movie Star Turned Hair Care Mogulat CNBC(Fri, May 17)
- Midday Glance: Pharmaceuticals companiesAP(Fri, May 17)
- Midday Glance: Medical Devices companiesAP(Fri, May 17)
- J&J Phasing Out Metal Hip Replacements and 2 Other Dow Movers to Watchat Wall St. Cheat Sheet(Fri, May 17)
- J&J's DePuy to end 2 hip replacement systemsAP(Fri, May 17)
- Good News For Health Care Stocks Part 2at Motley Fool(Fri, May 17)
Key Statistics
| Forward P/E (1 yr): | 15.24 |
|---|
| P/S (ttm): | 3.58 |
|---|
| Ex-Dividend Date: | 23-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 5.41 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.39 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 2.55 |
|---|
Business Summary
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide.
View More